Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1900 1
1908 1
1912 1
1914 1
1916 1
1918 1
1920 1
1929 1
1934 1
1945 1
1946 7
1947 6
1948 2
1949 1
1951 2
1952 3
1953 1
1954 1
1955 1
1956 2
1957 5
1958 1
1959 5
1960 6
1961 1
1962 5
1964 3
1965 1
1966 4
1967 8
1968 6
1969 11
1970 21
1971 32
1972 17
1973 21
1974 17
1975 24
1976 26
1977 15
1978 25
1979 18
1980 15
1981 24
1982 25
1983 28
1984 39
1985 27
1986 29
1987 43
1988 38
1989 43
1990 32
1991 48
1992 59
1993 58
1994 56
1995 51
1996 69
1997 63
1998 62
1999 61
2000 86
2001 77
2002 63
2003 81
2004 84
2005 95
2006 105
2007 94
2008 93
2009 94
2010 121
2011 128
2012 135
2013 130
2014 133
2015 144
2016 134
2017 137
2018 142
2019 186
2020 198
2021 237
2022 186
2023 219
2024 216
2025 195
2026 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,367 results

Results by year

Filters applied: . Clear all
Page 1
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M; CONFIDENCE Investigators. Agarwal R, et al. Among authors: scott c. N Engl J Med. 2025 Aug 7;393(6):533-543. doi: 10.1056/NEJMoa2410659. Epub 2025 Jun 5. N Engl J Med. 2025. PMID: 40470996 Clinical Trial.
Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair.
De Ponti FF, Bujko A, Liu Z, Collins PJ, Schuermans S, Maueroder C, Amstelveen S, Thoné T, Martens L, McKendrick JG, Louwe PA, Sànchez Cruz A, Saelens W, Matchett KP, Waller KJ, Zwicker C, Buglar-Lamb A, Vanneste B, Parmentier F, Binte Abdul Latib M, Remmerie A, Kertesz L, Kremer A, Verbeke J, Ipsen DH, Pfister DR, Liu Z, Guilliams M, Henderson NC, Ravichandran K, Marques PE, Scott CL. De Ponti FF, et al. Among authors: scott cl. Immunity. 2025 Feb 11;58(2):362-380.e10. doi: 10.1016/j.immuni.2025.01.002. Epub 2025 Jan 24. Immunity. 2025. PMID: 39862865 Free article.
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
Marks ZRC, Campbell NK, Mangan NE, Vandenberg CJ, Gearing LJ, Matthews AY, Gould JA, Tate MD, Wray-McCann G, Ying L, Rosli S, Brockwell N, Parker BS, Lim SS, Bilandzic M, Christie EL, Stephens AN, de Geus E, Wakefield MJ, Ho GY, McNally O; Australian Ovarian Cancer Study; McNeish IA, Bowtell DDL, de Weerd NA, Scott CL, Bourke NM, Hertzog PJ. Marks ZRC, et al. Among authors: scott cl. Nature. 2023 Aug;620(7976):1063-1070. doi: 10.1038/s41586-023-06421-w. Epub 2023 Aug 16. Nature. 2023. PMID: 37587335
NBAtlas: A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors.
Bonine N, Zanzani V, Van Hemelryk A, Vanneste B, Zwicker C, Thoné T, Roelandt S, Bekaert SL, Koster J, Janoueix-Lerosey I, Thirant C, Van Haver S, Roberts SS, Mus LM, De Wilde B, Van Roy N, Everaert C, Speleman F, Vermeirssen V, Scott CL, De Preter K. Bonine N, et al. Among authors: scott cl. Cell Rep. 2024 Oct 22;43(10):114804. doi: 10.1016/j.celrep.2024.114804. Epub 2024 Oct 3. Cell Rep. 2024. PMID: 39368085 Free article.
Preface: Pediatric rheumatology.
Scott C, Hissink Muller P. Scott C, et al. Best Pract Res Clin Rheumatol. 2024 Sep;38(3):102004. doi: 10.1016/j.berh.2024.102004. Epub 2024 Sep 18. Best Pract Res Clin Rheumatol. 2024. PMID: 39294013 No abstract available.
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial.
Heerspink HJL, Birkenfeld AL, Cherney DZI, Colhoun HM, Ji L, Mathieu C, Groop PH, Pratley RE, Rosas SE, Rossing P, Skyler JS, Tuttle KR, Lawatscheck R, Scott C, Edfors R, Scheerer MF, Kolkhof P, McGill JB. Heerspink HJL, et al. Among authors: scott c. Diabetes Res Clin Pract. 2023 Oct;204:110908. doi: 10.1016/j.diabres.2023.110908. Epub 2023 Oct 5. Diabetes Res Clin Pract. 2023. PMID: 37805000 Free article.
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M; CONFIDENCE investigators. Agarwal R, et al. Among authors: scott c. Nephrol Dial Transplant. 2025 Aug 1;40(8):1559-1569. doi: 10.1093/ndt/gfaf022. Nephrol Dial Transplant. 2025. PMID: 39916475 Free PMC article. Clinical Trial.
Kupffer cell programming by maternal obesity triggers fatty liver disease.
Huang H, Balzer NR, Seep L, Splichalova I, Blank-Stein N, Viola MF, Franco Taveras E, Acil K, Fink D, Petrovic F, Makdissi N, Bayar S, Mauel K, Radwaniak C, Zurkovic J, Kayvanjoo AH, Wunderling K, Jessen M, Yaghmour MH, Kenner L, Ulas T, Grein S, Schultze JL, Scott CL, Guilliams M, Liu Z, Ginhoux F, Beyer MD, Thiele C, Meissner F, Hasenauer J, Wachten D, Mass E. Huang H, et al. Among authors: scott cl. Nature. 2025 Aug;644(8077):790-798. doi: 10.1038/s41586-025-09190-w. Epub 2025 Jun 18. Nature. 2025. PMID: 40533564 Free PMC article.
Understanding the complex macrophage landscape in MASLD.
De Ponti FF, Liu Z, Scott CL. De Ponti FF, et al. Among authors: scott cl. JHEP Rep. 2024 Aug 23;6(11):101196. doi: 10.1016/j.jhepr.2024.101196. eCollection 2024 Nov. JHEP Rep. 2024. PMID: 39524202 Free PMC article. Review.
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project.
Baldo F, Erkens RGA, Mizuta M, Rogani G, Lucioni F, Bracaglia C, Foell D, Gattorno M, Jelusic M, Anton J, Brogan P, Canna S, Chandrakasan S, Cron RQ, De Benedetti F, Grom A, Heshin-Bekenstein M, Horne A, Khubchandani R, Ozen S, Quartier P, Ravelli A, Shimizu M, Schulert G, Scott C, Sinha R, Ruperto N, Swart JF, Vastert S, Minoia F; PReS MAS/sJIA Working Party and Paediatric Rheumatology International Trial Organization. Baldo F, et al. Among authors: scott c. Rheumatology (Oxford). 2025 Jan 1;64(1):32-44. doi: 10.1093/rheumatology/keae391. Rheumatology (Oxford). 2025. PMID: 39058514 Free PMC article.
4,367 results